Kim Jiyeong, Ahn Seong Joon
Department of Pre-Medicine, College of Medicine, and Biostatistics Lab, Medical Research Collaborating Center (MRCC), Hanyang University, Seoul 04763, Republic of Korea.
Department of Ophthalmology, Hanyang University Hospital, Hanyang University College of Medicine, Seoul 04763, Republic of Korea.
J Clin Med. 2024 Aug 27;13(17):5090. doi: 10.3390/jcm13175090.
: This study investigated the practice patterns of pentosan polysulfate (PPS) maculopathy screening in various clinical settings and demographic and clinical characteristics associated with these screening practices using a health claims database. : In this nationwide population-based study, data from the Health Insurance Review and Assessment database in South Korea were analyzed to identify patients who underwent PPS. The participants were categorized based on whether they had undergone a baseline examination (the first ophthalmic examination since PPS prescription) within one year of PPS use, subsequent monitoring within one year of the baseline examination, or recent monitoring within a 1-year period before the study end date. Demographic and clinical factors were compared between the groups, and factors associated with screening practices were identified using logistic regression analyses. : Significant differences in screening practices were observed based on sex, age, residence, the medical specialty of the prescribing physician, indications for PPS use, and hospital type of prescription. Older patients who received PPS prescriptions from urologists were more likely to undergo baseline and monitoring examinations. Logistic regression analyses revealed that older age, female sex, and a longer duration of PPS use were significantly associated with baseline screening. Subsequent and recent monitoring was significantly associated with age, duration of PPS use, and treatment at primary hospitals. : This study underscores the variability in screening practices for PPS users based on demographic and clinical factors, emphasizing the need for standardized guidelines. Enhanced awareness and timely referral for maculopathy screening, particularly among non-urological specialties, are essential.
本研究利用健康保险理赔数据库,调查了戊聚糖多硫酸盐(PPS)黄斑病变筛查在不同临床环境中的实践模式,以及与这些筛查实践相关的人口统计学和临床特征。
在这项基于全国人口的研究中,分析了韩国健康保险审查与评估数据库中的数据,以识别接受PPS治疗的患者。参与者根据是否在使用PPS的一年内进行了基线检查(自PPS处方后的首次眼科检查)、在基线检查后的一年内进行了后续监测,或在研究结束日期前的1年期间内进行了近期监测进行分类。比较了各组之间的人口统计学和临床因素,并使用逻辑回归分析确定了与筛查实践相关的因素。
基于性别、年龄、居住地、开处方医生的医学专业、PPS使用指征和处方医院类型,观察到筛查实践存在显著差异。从泌尿科医生处接受PPS处方的老年患者更有可能接受基线检查和监测检查。逻辑回归分析显示,年龄较大、女性以及使用PPS的时间较长与基线筛查显著相关。后续和近期监测与年龄、使用PPS的时间以及在基层医院的治疗显著相关。
本研究强调了基于人口统计学和临床因素,PPS使用者筛查实践的变异性,强调了标准化指南的必要性。提高对黄斑病变筛查的认识并及时转诊,特别是在非泌尿科专业中,至关重要。